Global Structural Heart Imaging Market is Likely to Grow at a CAGR Value of Around 12.90% by 2028

The global structural heart imaging market size was worth USD 13,275.10 million in 2021 and is estimated to grow to USD 27,491.69 million by 2028, with a compound annual growth rate (CAGR) of around 12.90 percent during the forecast period. The report analyzes the structural heart imaging market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the structural heart imaging market.

Structural heart imaging (SHI) is an imaging technique that uses a high-resolution camera to screen the heart to produce clear images that help doctors accurately diagnose a patient's heart condition. Echocardiography and angiography (MRI, CT, etc.) are the most widely used structural imaging modalities to evaluate cardiac structure and identify narrowing or blockage of blood vessels. The key factors that are expected to drive the growth of the global structural heart imaging market during the forecast period are the increasing prevalence of cardiac heart disease (CHD) globally. In addition, increasing advances in imaging modality technology are expected to drive the growth of the market. In addition, increasing knowledge about heart diseases, including high blood pressure, could reduce the development of the market.

On the other hand, rising costs are expected to hinder the growth of the market during the forecast period. Furthermore, the increasing acceptance of advanced devices will present more potential opportunities for structural heart imaging market growth in the coming years. However, inadequate return policies may still challenge the development of the market in the near future.

The global structural heart imaging market is segregated based on imaging modality, procedure type, application, end-user, and region. By imaging modality, the market is divided into echocardiograms and angiograms. Among these, the angiogram segment is expected to dominate during the forecast period. By procedure type, the market is bifurcated into transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), transcatheter mitral valve repair (TMVR), left atrial appendage closure (LAAC), annuloplasty, valvuloplasty, and others.

Over the forecast period, the transcatheter aortic valve replacement (TAVR) segment is expected to account for the largest share of revenue. On the basis of application, diagnosis and surgery. In 2021, the diagnosis category dominated the global market. Based on end-user, the market is categorized into hospitals, specialty clinics, cardiac centers, diagnostic centers, ambulatory surgical centers, catheterization laboratories, and others. In 2021, the hospitals category had a major share.

In 2021, North America has the highest share of the global structural heart imaging market revenue. The incidence of congenital heart defects is increasing; there is a growing need for technology to enhance technology to treat structural heart disease, increasing adoption of lifestyle changes, growing awareness of structural illnesses, more preventive care, favorable government policies, clinical trials, and product introductions by significant players in the region are some of the factors that is expected to aid the market to grow during the forecast period. For example, according to the Centers for Disease Control and Prevention, the most common congenital disabilities are congenital heart defects (CCs), and babies are born with these problems. Coronary artery disease affects nearly 1% of births or about 40,000 births annually in the United States.

Some coronary heart diseases, especially mild forms, are increasing in prevalence (number of babies born with heart defects divided by the total number of babies born). At the same time, rates for other types are unchanged. A ventricular septal defect (VSD) is the most common type of heart defect. 1 out of 4 newborns has acute coronary artery disease. Newborns with severe coronary heart disease often need surgery or other procedures during their first year. Therefore, the North American region is expected to hold the largest market share during the forecast period because of the abovementioned factors.

Key market players in the global structural heart imaging market include Abbott Laboratories, Circle Cardiovascular Imaging Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Koninklijke Philips N.V., Integer Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, LivaNova PLC, Siemens Healthcare GmbH, and Pie Medical Imaging B.V.

Recent developments:

• In October 2021, NuVera Medical, Inc. published promising results from a non-randomized, single-center First-In-Human (FIH) study that investigated the feasibility of the NuVision ICE Catheter in visualizing the anatomical structures of patients undergoing surgical procedures. Structural heart procedures such as mitral or tricuspid valve repair or LAAC repair. The company is focusing on improving the effectiveness of catheter-based cardiac interventions through cutting-edge 4D ICE imaging.
• In November 2021, Abbott developed a minimally invasive valve repair device that can be used to treat mitral regurgitation. The product is considered an important treatment option for people with mitral regurgitation due to heart failure.

Browse the full “Global Structural Heart Imaging Market By Imaging Modality (Echocardiogram and Angiogram), By Procedure Type (Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Annuloplasty, Valvuloplasty, and Others), By Application (Diagnosis and Surgery), By End-User (Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers, Catheterization Laboratories, and Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/structural-heart-imaging-market

The global structural heart imaging market is segmented as follows:

By Imaging Modality

• Echocardiogram
• Angiogram

By procedure type

• Transcatheter Aortic Valve Replacement (TAVR) 
• Surgical Aortic Valve Replacement (SAVR) 
• Transcatheter Mitral Valve Repair (TMVR) 
• Left Atrial Appendage Closure (LAAC)
• Annuloplasty 
• Valvuloplasty
• Others

By Application

• Diagnosis
• Surgery

By End-user

• Hospitals 
• Specialty Clinics 
• Cardiac Centers 
• Diagnostic Centers 
• Ambulatory Surgical Centers 
• Catheterization Laboratories 
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com